Log In
Sign Up
Find a Lawyer
Ask a Lawyer
Research the Law
Law Schools
Laws & Regs
Newsletters
Marketing Solutions
Justia Connect
Pro Membership
Basic Membership
Justia Lawyer Directory
Platinum Placements
Gold Placements
Justia Elevate
SEO
Websites
Blogs
Justia Amplify
PPC Management
Google Business Profile
Social Media
Justia Onward Blog
Justia
Patents
Patents Assigned to Synapsin Pharmaceuticals, Inc.
Patents Assigned to Synapsin Pharmaceuticals, Inc.
Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance
Patent number:
9943554
Abstract:
Provided herein are piperidine alkaloids and uses thereof in neurological disorders and physical enhancement applications.
Type:
Grant
Filed:
January 25, 2016
Date of Patent:
April 17, 2018
Assignee:
SYNAPSIN PHARMACEUTICALS, INC.
Inventors:
Denis Dorsey, Mark S. Kindy
Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing physical performance
Patent number:
9259419
Abstract:
Provided herein are piperidine alkaloids and uses thereof in neurological disorders and physical enhancement applications.
Type:
Grant
Filed:
August 15, 2013
Date of Patent:
February 16, 2016
Assignee:
SYNAPSIN PHARMACEUTICALS, INC.
Inventors:
Denis Dorsey, Mark S. Kindy
Compositions And Methods Relating To Solenopsins And Their Uses In Treating Neurological Disorders And Enhancing Physical Performance
Publication number:
20140086998
Abstract:
Provided herein are piperidine alkaloids and uses thereof in neurological disorders and physical enhancement applications.
Type:
Application
Filed:
August 15, 2013
Publication date:
March 27, 2014
Applicant:
SYNAPSIN PHARMACEUTICALS, INC.
Inventors:
DENIS DORSEY, MARK S. KINDY
Compositions and methods relating to solenopsins and their uses in treating neurological disorders and enhancing cognitive and physical performance
Patent number:
8524741
Abstract:
Provided herein are piperidine alkaloids and uses thereof in neurological disorders and physical enhancement applications.
Type:
Grant
Filed:
July 9, 2007
Date of Patent:
September 3, 2013
Assignee:
Synapsin Pharmaceuticals, Inc.
Inventors:
Denis Dorsey, Mark S. Kindy